Leveraging Artificial Intelligence for Studying and Treating Parkinson’s Disease
Drugs that aim to treat Parkinson’s disease (PD) have not fared well in clinical trials, suggesting that there is more to PD than we currently understand....
79 Results
Clear Filters
Showing Up for Science: Celebrities and Stem Cells Take Center Stage at the NYSCF Gala
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
Consortium Including NYSCF Scientists Receives Grant Award to Study Parkinson’s Disease Risk Factors
A multi-institutional team of scientists led by Lorenz Studer, MD (Memorial Sloan Kettering Cancer Center) and including Gist Croft, PhD (The NYSCF Research Institute), NYSCF –...
Does Brain Inflammation Trigger Neurodegeneration? If So, it Could Open the Door for New Therapies
Today, more than 6 million Americans suffer from neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis, and as our society ages, that number is only...
NYSCF Scientists Create the ‘Stars’ of the Brain and Capture Their Rogue Behavior in Disease
Read the press release here. You may not have heard of astrocytes before, but your body is full of them: they make up more than...
When Astrocytes Attack: Stem Cell Model Shows Possible Mechanism Behind Neurodegeneration
Human stem-cell-derived astrocytes can be triggered to become toxic to neurons, opening the door for new understanding and treatment of neurodegenerative diseases. Featured image credit: Christina...
NYSCF Scientists Talk Space, Stem Cells, and their Pioneering Study of MS and PD
The International Space Station (ISS) houses more than astronauts: the football-field-sized spacecraft is also home to a large range of research projects carried out in the...
2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
NYSCF Collaboration Sends Multiple Sclerosis and Parkinson’s Disease Brain Cells to Space
Brain cells derived from the stem cells of multiple sclerosis and Parkinson’s disease patients are on their way up to the International Space Station! This afternoon,...
First-in-kind Human 3-dimensional Models of Parkinson’s Disease and Progressive Multiple Sclerosis Launching to the International Space Station
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...
Precision Medicine and the Power of Stem Cells: Highlights of the 2019 NYSCF Conference
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
Stem Cells Take to Space: NYSCF Collaboration Launches the First 3D Models of Parkinson’s Disease and Multiple Sclerosis to the International Space Station
On Thursday evening, SpaceX cargo flight CRS-18 took off from Cape Canaveral, bound for the International Space Station (ISS). Aboard for the 250-mile journey were brain...
Translational Research Takes Center Stage at NYSCF Conference
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
Unique Collaboration Utilizing the International Space Station Accelerates Parkinson’s Disease and Multiple Sclerosis Research
The National Stem Cell Foundation (NSCF), Summit for Stem Cell Foundation, The New York Stem Cell Foundation (NYSCF) Research Institute, and Space Tango today announced a...
NYSCF Announces 2018 Class of NYSCF – Robertson Investigators
NEW YORK, NY (October 23, 2018) – The New York Stem Cell Foundation (NYSCF) announced the 2018 class of NYSCF – Robertson Investigators, welcoming six of...
NYSCF Hosts Panel Discussion on Parkinson’s Disease Research and Treatment
Years ago, a physician in her sixties started to develop a tremor. She sought treatment from Dr. Susan Bressman, who diagnosed her with Parkinson’s disease. The...
New York Stem Cell Foundation Research Institute and Tufts University to Collaborate on Neurodegeneration
Scientific teams will develop advanced stem cell models to improve understanding and treatment of Parkinson’s, Alzheimer’s, and similar diseases New York, NY (September 12, 2018) –...
Dr. Gist Croft Joins NYSCF to Lead Parkinson’s Disease Research
We are pleased to announce that Gist Croft, PhD, has joined NYSCF as a Senior Principal Investigator in Parkinson’s disease and Neurodegeneration. Dr. Croft— an expert...
NYSCF – Robertson Investigator Partners With Novo Nordisk to Produce Therapy For Parkinson’s Disease
NYSCF – Robertson Investigator Malin Parmar, PhD, Professor at Lund University, Sweden, is beginning a collaboration with Novo Nordisk, one of the world’s largest pharmaceutical companies, to...
NYSCF Chief Medical Officer Dr. Melissa Nirenberg Speaks At American Academy of Neurology Annual Conference
NYSCF’s Chief Medical Officer Melissa Nirenberg, MD, PhD, spoke at the American Academy of Neurology’s annual conference in Los Angeles. This meeting convenes medical professionals, students,...
Four NYSCF Innovators Featured In Nature Article on Embryonic Stem Cell Research
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
Unique and Comprehensive Collection of Stem Cell Lines Available to Researchers Around the Globe
NYSCF and the Beyond Batten Disease Foundation (BBDF) partnered to create a unique and comprehensive collection of juvenile Batten (CLN3) disease induced pluripotent stem (iPS) cells....
NYSCF Innovator’s Parkinson’s Disease Breakthroughs
NYSCF – Robertson Stem Cell Investigator Dr. Malin Parmar, a Professor at Lund University in Sweden, published a flurry of papers this summer all describing exciting...
Dr. Melissa Nirenberg Joins NYSCF as Chief Medical Officer
Melissa Nirenberg, MD, PhD is joining NYSCF this September in a newly created role of Chief Medical Officer. Dr. Nirenberg comes to NYSCF from the NYU...
Noninvasive Deep Brain Stimulation
Deep brain stimulation via implanted electrodes has proven an effective therapy for Parkinson’s disease, epilepsy, and depression among other disorders; however, it remains an invasive and...